GrowingStockReport.com

Dollar Tree, Inc. (NASDAQ:DLTR) and Celldex Therapeutics, Inc. (NASDAQ:CLDX) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/12/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Dollar Tree, Inc. (NASDAQ:DLTR) and Celldex Therapeutics, Inc. (NASDAQ:CLDX).

Dollar Tree, Inc. (NASDAQ:DLTR) a company that operates discount variety stores in the United States and Canada closed up in its previous session (+0.47%) on 1,913,260 shares traded. Dollar Tree, Inc. (NASDAQ:DLTR) is currently up (+48.65%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Dollar Tree, Inc. (NASDAQ:DLTR)

Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States closed down in its previous session (-7.28%) on 2,994,959 shares traded after Celldex Announced Exercise of Underwriters' Option to Purchase Additional Shares. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently down (-42.69%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com